Login / Signup

Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study.

Asher CohenJohn A NaslundSarah ChangSrilakshmi NagendraAnant BhanAbhijit RozatkarJagadisha ThirthalliAmeya BondreDeepak TugnawatPreethi V ReddySiddharth DuttSoumya ChoudharyPrabhat Kumar ChandVikram PatelMatcheri KeshavanDevayani JoshiUrvakhsh Meherwan MehtaJohn B Torous
Published in: Schizophrenia (Heidelberg, Germany) (2023)
Smartphone technology provides us with a more convenient and less intrusive method of detecting changes in behavior and symptoms that typically precede schizophrenia relapse. To take advantage of the aforementioned, this study examines the feasibility of predicting schizophrenia relapse by identifying statistically significant anomalies in patient data gathered through mindLAMP, an open-source smartphone app. Participants, recruited in Boston, MA in the United States, and Bangalore and Bhopal in India, were invited to use mindLAMP for up to a year. The passive data (geolocation, accelerometer, and screen state), active data (surveys), and data quality metrics collected by the app were then retroactively fed into a relapse prediction model that utilizes anomaly detection. Overall, anomalies were 2.12 times more frequent in the month preceding a relapse and 2.78 times more frequent in the month preceding and following a relapse compared to intervals without relapses. The anomaly detection model incorporating passive data proved a better predictor of relapse than a naive model utilizing only survey data. These results demonstrate that relapse prediction models utilizing patient data gathered by a smartphone app can warn the clinician and patient of a potential schizophrenia relapse.
Keyphrases
  • electronic health record
  • free survival
  • bipolar disorder
  • big data
  • case report
  • physical activity
  • risk assessment
  • high throughput
  • cross sectional
  • deep learning
  • human health